[1]
S. Savić, I. Pantelić, I. Jančić, and M. Savić, “Neuroimmune aspects of mood, anxiety and cognitive effects of leads/drug candidates acting at GABAA and/or sigma-2 receptors: In vitro/in vivo delineation by nano- and hiPSC-based platforms”, arhfarm, vol. 72, no. Suppl. 4, pp. S169-S170, Oct. 2022, Accessed: Nov. 19, 2026. Available: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/38540